MIPE for Pilonidal Disease
Public ClinicalTrials.gov record NCT03772873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Minimally Invasive Pilonidal Excision for the Treatment of Pilonidal Disease - A Multi-Center Non-Randomized Controlled Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Pilonidal disease often presents as a chronic, relapsing condition. A variety of procedures are used in the management of pilonidal disease, with varying degrees of morbidity, disease-free interval, and long-term success. In patients with new-onset or recurrent pilonidal disease, the investigators aim to address how minimally invasive trephine excision compares to other surgical procedures in terms of short- and long-term clinical outcomes and patient satisfaction. In the absence of a gold standard surgical procedure, surgeon preference will help dictate the management of pilonidal disease. For many surgeons, this means a variation on open excision for pilonidal disease failing conservative management. However, outcomes for minimally invasive pilonidal excision (MIPE) as initially described by Gips and forthcoming Lipskar et al., are likely to alter management of the disease (Gips, 2008). The investigators wish to assess patient and surgeon satisfaction with MIPE, and short-term outcomes.
Study identification
- NCT ID
- NCT03772873
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 151 participants
Conditions and interventions
Conditions
- Pilonidal Disease
- Pilonidal Cyst/Fistula
- Pilonidal Sinus Without Abscess
- Pilonidal Cyst Without Abscess
- Pilonidal Cyst and Sinus Without Abscess
- Pilonidal Abscess
- Pilonidal Sinus With Abscess
- Pilonidal Dimple With Abscess
- Pilonidal Fistula With Abscess
- Pilonidal Sinus Infected
- Pilonidal Cyst With Sinus
- Pilonidal Cyst and Sinus With Abscess
- Pilonidal Disease of Natal Cleft Abscess
Eligibility (public fields only)
- Age range
- 2 Years to 25 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2018
- Primary completion
- May 31, 2026
- Completion
- May 31, 2026
- Last update posted
- Nov 16, 2022
2019 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | — |
| Advocate Health Center | Park Ridge | Illinois | 60068 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Cohen Children's Medical Center | New Hyde Park | New York | 11040 | — |
| Dayton Children's Hospital | Dayton | Ohio | 45404 | — |
| Lehigh Valley Reilly Children's Hospital | Allentown | Pennsylvania | 18104 | — |
| LeBonheur Children's Hospital | Memphis | Tennessee | 38105 | — |
| Children's Medical Center Dallas | Dallas | Texas | 75235 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03772873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2022 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03772873 live on ClinicalTrials.gov.